ID

38168

Beschrijving

A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay; ODM derived from: https://clinicaltrials.gov/show/NCT01899079

Link

https://clinicaltrials.gov/show/NCT01899079

Trefwoorden

  1. 24-09-19 24-09-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

24 september 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT01899079

Eligibility Breast Cancer NCT01899079

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
resected node-negative, estrogen-receptor-positive, her2-negative early- stage invasive breast cancer (t1-t2, n0, pn0 (i+), pn0 (mol+), m0)
Beschrijving

Invasive carcinoma of breast Early stage TNM Breast tumor staging | Invasive carcinoma of breast Resected Negative Lymph Node | Invasive carcinoma of breast Estrogen receptor positive HER2 Negative

Datatype

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C2363430
UMLS CUI [1,3]
C0474926
UMLS CUI [2,1]
C0853879
UMLS CUI [2,2]
C1521996
UMLS CUI [2,3]
C0678034
UMLS CUI [3,1]
C0853879
UMLS CUI [3,2]
C0279754
UMLS CUI [3,3]
C2348908
1. estrogen receptor status will be evaluated by immunohistochemistry (ihc)and more than 1% of stained tumor cells will be considered positive.
Beschrijving

Estrogen Receptor Status Immunohistochemistry

Datatype

boolean

Alias
UMLS CUI [1,1]
C1516974
UMLS CUI [1,2]
C0021044
2. her2 status will be evaluated by (ihc; 0 or 1+, or 2+ will be considered negative) and by in-situ fluorescence hybridization.
Beschrijving

HER2 Status Immunohistochemistry | HER2 Status Fluorescent in Situ Hybridization

Datatype

boolean

Alias
UMLS CUI [1,1]
C1512413
UMLS CUI [1,2]
C0021044
UMLS CUI [2,1]
C1512413
UMLS CUI [2,2]
C0162789
postmenopausal females, which is defined as:
Beschrijving

Postmenopausal state

Datatype

boolean

Alias
UMLS CUI [1]
C0232970
1. natural amenorrhea > 12 months, regardless of age
Beschrijving

Amenorrhea Natural Duration | Independent of Age

Datatype

boolean

Alias
UMLS CUI [1,1]
C0002453
UMLS CUI [1,2]
C0205296
UMLS CUI [1,3]
C0449238
UMLS CUI [2,1]
C0332291
UMLS CUI [2,2]
C0001779
2. bilateral oophorectomy, regardless of age (the oophorectomy must have been carried out at least 4 weeks before entering the study)
Beschrijving

Bilateral oophorectomy | Independent of Age

Datatype

boolean

Alias
UMLS CUI [1]
C0278321
UMLS CUI [2,1]
C0332291
UMLS CUI [2,2]
C0001779
3. radiological castration with amenorrhea > 3 months, regardless of age
Beschrijving

Castration Radiologic | Amenorrhea Duration | Independent of Age

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007344
UMLS CUI [1,2]
C0205483
UMLS CUI [2,1]
C0002453
UMLS CUI [2,2]
C0449238
UMLS CUI [3,1]
C0332291
UMLS CUI [3,2]
C0001779
4. hysterectomy and postmenopausal blood levels
Beschrijving

Hysterectomy | Blood Level Postmenopausal

Datatype

boolean

Alias
UMLS CUI [1]
C0020699
UMLS CUI [2,1]
C0005767
UMLS CUI [2,2]
C0441889
UMLS CUI [2,3]
C0232970
able to give consent
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
eligible for treatment of breast cancer with adjuvant chemotherapy
Beschrijving

Eligibility Adjuvant Chemotherapy Breast Carcinoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C1548635
UMLS CUI [1,2]
C0085533
UMLS CUI [1,3]
C0678222
ecog performance status of 0 or 1
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
tumor size t3-t4
Beschrijving

Tumor size TNM Breast tumor staging

Datatype

boolean

Alias
UMLS CUI [1,1]
C0475440
UMLS CUI [1,2]
C0474926
non-invasive breast cancer (e.g., paget's disease, dcis)
Beschrijving

Breast Carcinoma Non-invasive | Paget Disease | DCIS

Datatype

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0205303
UMLS CUI [2]
C1368019
UMLS CUI [3]
C0007124
tumors with nodes that are not n0, pn0 (i+), or pn0 (mol+)
Beschrijving

Cancer of lymph node TNM clinical staging

Datatype

boolean

Alias
UMLS CUI [1,1]
C0948627
UMLS CUI [1,2]
C3258246
tumors that are estrogen-receptor negative or her2 positive
Beschrijving

Neoplasms Estrogen receptor negative | Neoplasms HER2 positive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0279756
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C2348909
have metastatic disease
Beschrijving

Neoplasm Metastasis

Datatype

boolean

Alias
UMLS CUI [1]
C0027627
unable to give informed consent
Beschrijving

Informed Consent Unable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
unable to complete patient reported outcome surveys
Beschrijving

Outcome Surveys Completion Unable

Datatype

boolean

Alias
UMLS CUI [1,1]
C1274040
UMLS CUI [1,2]
C0038951
UMLS CUI [1,3]
C0205197
UMLS CUI [1,4]
C1299582
have contraindications for adjuvant chemotherapy
Beschrijving

Medical contraindication Adjuvant Chemotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0085533
age, performance status, significant comorbidities
Beschrijving

Age | Performance status | Comorbidity Significant

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C1518965
UMLS CUI [3,1]
C0009488
UMLS CUI [3,2]
C0750502
ecog performance status > 1
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224

Similar models

Eligibility Breast Cancer NCT01899079

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Invasive carcinoma of breast Early stage TNM Breast tumor staging | Invasive carcinoma of breast Resected Negative Lymph Node | Invasive carcinoma of breast Estrogen receptor positive HER2 Negative
Item
resected node-negative, estrogen-receptor-positive, her2-negative early- stage invasive breast cancer (t1-t2, n0, pn0 (i+), pn0 (mol+), m0)
boolean
C0853879 (UMLS CUI [1,1])
C2363430 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,3])
C0853879 (UMLS CUI [2,1])
C1521996 (UMLS CUI [2,2])
C0678034 (UMLS CUI [2,3])
C0853879 (UMLS CUI [3,1])
C0279754 (UMLS CUI [3,2])
C2348908 (UMLS CUI [3,3])
Estrogen Receptor Status Immunohistochemistry
Item
1. estrogen receptor status will be evaluated by immunohistochemistry (ihc)and more than 1% of stained tumor cells will be considered positive.
boolean
C1516974 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])
HER2 Status Immunohistochemistry | HER2 Status Fluorescent in Situ Hybridization
Item
2. her2 status will be evaluated by (ihc; 0 or 1+, or 2+ will be considered negative) and by in-situ fluorescence hybridization.
boolean
C1512413 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])
C1512413 (UMLS CUI [2,1])
C0162789 (UMLS CUI [2,2])
Postmenopausal state
Item
postmenopausal females, which is defined as:
boolean
C0232970 (UMLS CUI [1])
Amenorrhea Natural Duration | Independent of Age
Item
1. natural amenorrhea > 12 months, regardless of age
boolean
C0002453 (UMLS CUI [1,1])
C0205296 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0332291 (UMLS CUI [2,1])
C0001779 (UMLS CUI [2,2])
Bilateral oophorectomy | Independent of Age
Item
2. bilateral oophorectomy, regardless of age (the oophorectomy must have been carried out at least 4 weeks before entering the study)
boolean
C0278321 (UMLS CUI [1])
C0332291 (UMLS CUI [2,1])
C0001779 (UMLS CUI [2,2])
Castration Radiologic | Amenorrhea Duration | Independent of Age
Item
3. radiological castration with amenorrhea > 3 months, regardless of age
boolean
C0007344 (UMLS CUI [1,1])
C0205483 (UMLS CUI [1,2])
C0002453 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0332291 (UMLS CUI [3,1])
C0001779 (UMLS CUI [3,2])
Hysterectomy | Blood Level Postmenopausal
Item
4. hysterectomy and postmenopausal blood levels
boolean
C0020699 (UMLS CUI [1])
C0005767 (UMLS CUI [2,1])
C0441889 (UMLS CUI [2,2])
C0232970 (UMLS CUI [2,3])
Informed Consent
Item
able to give consent
boolean
C0021430 (UMLS CUI [1])
Eligibility Adjuvant Chemotherapy Breast Carcinoma
Item
eligible for treatment of breast cancer with adjuvant chemotherapy
boolean
C1548635 (UMLS CUI [1,1])
C0085533 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Tumor size TNM Breast tumor staging
Item
tumor size t3-t4
boolean
C0475440 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
Breast Carcinoma Non-invasive | Paget Disease | DCIS
Item
non-invasive breast cancer (e.g., paget's disease, dcis)
boolean
C0678222 (UMLS CUI [1,1])
C0205303 (UMLS CUI [1,2])
C1368019 (UMLS CUI [2])
C0007124 (UMLS CUI [3])
Cancer of lymph node TNM clinical staging
Item
tumors with nodes that are not n0, pn0 (i+), or pn0 (mol+)
boolean
C0948627 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Neoplasms Estrogen receptor negative | Neoplasms HER2 positive
Item
tumors that are estrogen-receptor negative or her2 positive
boolean
C0027651 (UMLS CUI [1,1])
C0279756 (UMLS CUI [1,2])
C0027651 (UMLS CUI [2,1])
C2348909 (UMLS CUI [2,2])
Neoplasm Metastasis
Item
have metastatic disease
boolean
C0027627 (UMLS CUI [1])
Informed Consent Unable
Item
unable to give informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Outcome Surveys Completion Unable
Item
unable to complete patient reported outcome surveys
boolean
C1274040 (UMLS CUI [1,1])
C0038951 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
Medical contraindication Adjuvant Chemotherapy
Item
have contraindications for adjuvant chemotherapy
boolean
C1301624 (UMLS CUI [1,1])
C0085533 (UMLS CUI [1,2])
Age | Performance status | Comorbidity Significant
Item
age, performance status, significant comorbidities
boolean
C0001779 (UMLS CUI [1])
C1518965 (UMLS CUI [2])
C0009488 (UMLS CUI [3,1])
C0750502 (UMLS CUI [3,2])
ECOG performance status
Item
ecog performance status > 1
boolean
C1520224 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial